NEKTAR THERAPEUTICS - COM (NKTR)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
113 M
Holdings value Q1 2024
$105 M
Value change Q1 2024
-$4.45 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
116
Number of buys Q1 2024
1
Number of sells Q1 2024
0
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0
CUSIP
640268108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 87.2 K $108 K +$35.2 K $1.24 4
2024 Q1 113 M $105 M -$4.45 M $0.93 117
2023 Q4 119 M $66.9 M -$13.9 M $0.57 116
2023 Q3 142 M $84.6 M +$3.8 M $0.60 126
2023 Q2 136 M $78.1 M -$21.6 M $0.58 136
2023 Q1 171 M $120 M -$6.86 M $0.70 185
2022 Q4 169 M $381 M -$29 M $2.26 205
2022 Q3 172 M $549 M -$31.8 M $3.20 204
2022 Q2 182 M $692 M +$13.4 M $3.80 206
2022 Q1 175 M $944 M -$13.3 M $5.39 219
2021 Q4 174 M $2.35 B +$60.9 M $13.51 230
2021 Q3 167 M $3.01 B -$15.4 M $17.96 226
2021 Q2 168 M $2.88 B -$32.8 M $17.16 227
2021 Q1 169 M $3.39 B -$52.6 M $20.00 224
2020 Q4 172 M $2.93 B -$16.1 M $17.00 227
2020 Q3 175 M $2.91 B -$42.1 M $16.59 232
2020 Q2 175 M $4.05 B -$44.3 M $23.16 249
2020 Q1 176 M $3.15 B +$17.9 M $17.85 222
2019 Q4 175 M $3.79 B -$40.8 M $21.59 265
2019 Q3 178 M $3.24 B +$141 M $18.22 271
2019 Q2 166 M $5.89 B +$834 M $35.58 327
2019 Q1 163 M $5.46 B -$79.4 M $33.60 334
2018 Q4 163 M $5.36 B +$26.2 M $32.87 324
2018 Q3 159 M $9.71 B -$26.6 M $60.96 373
2018 Q2 160 M $7.82 B -$143 M $48.83 366
2018 Q1 157 M $16.7 B +$348 M $106.26 352
2017 Q4 155 M $9.25 B +$89.5 M $59.72 263
2017 Q3 154 M $3.69 B +$66.2 M $24.00 204
2017 Q2 151 M $2.96 B +$123 M $19.55 198
2017 Q1 146 M $3.43 B +$472 M $23.47 200
2016 Q4 145 M $1.78 B +$107 M $12.27 194
2016 Q3 134 M $2.29 B -$7.26 M $17.18 190
2016 Q2 134 M $1.91 B -$65.7 M $14.23 175
2016 Q1 139 M $1.91 B -$6.78 M $13.75 173
2015 Q4 139 M $2.35 B -$22.1 M $16.85 177
2015 Q3 140 M $1.54 B +$33.6 M $10.96 162
2015 Q2 138 M $1.73 B +$152 M $12.51 181
2015 Q1 126 M $1.39 B +$59.7 M $11.00 153
2014 Q4 120 M $1.86 B +$32.2 M $15.50 164
2014 Q3 118 M $1.43 B +$50.2 M $12.07 145
2014 Q2 114 M $1.46 B -$20.6 M $12.82 143
2014 Q1 116 M $1.4 B +$165 M $12.12 140